Starting from the second day, Wanjiang Real Estate Company once again showed the enterprising spirit when it opened up the real estate market in Japan - savage expansion!

There is a saying, "strategic expansion, talent first".

Many enterprises blindly expand and finally fail, which can be summarized into two main internal reasons: the first is that the talent is not supported, and the second is that the management system is not supported.

After all, Wanjiang Real Estate is to fully enter the domestic real estate market, involving many projects, so it needs a lot of talents.

Therefore, the first step for Wujiang Real Estate is to recruit people.

Although Wanjiang Real Estate Company has cultivated some talents by itself, it is far from enough.

Architectural model designers, budgeters, engineering cost engineers, marketing planners, accountants, human resource management professionals and project management talents, etc...... They are all personnel urgently needed by Wanjiang Real Estate Company.

Wanjiang Real Estate's job advertisements soon appeared on the Internet, TV stations, newspapers and other media.

Due to the high salary of Wanjiang Real Estate, many people try to apply for positions in Wanjiang Real Estate Company.

……

There is no doubt that the real estate industry is very profitable, and God will not be able to accept it.

Although this may lead to an increase in housing prices in the future, having a large real estate company in your hands can at least exert influence on the industry and make some changes to the bad atmosphere.

At this moment, the entire Wanjiang Real Estate Company is running efficiently like a machine, and CEO Xu Shengzhe is already busy with his feet not touching the ground, but the spirit on his face has not decreased at all.

After more than a month of preparation.

Xu Shengzhe organized 20 teams to go to 20 cities across the country to open up the real estate market, namely Shanghai, BJ, Shenzhen, Guangzhou, Chongqing, Suzhou, Chengdu, Hangzhou, Nanjing, Wuhan, Tianjin, Ningbo, Qingdao, Changsha, Wuxi, Zhengzhou, Foshan, Nantong, Jinan and Xi'an.

This is the arrangement of the first batch of personnel, and Wanjiang Real Estate Company will set up more teams and go to more cities in the future.

Wanjiang Real Estate Company is not short of money, and the expansion speed is as fast as lightning compared with other real estate companies.

Xu Shengzhe is full of hope for the future of Wanjiang Real Estate Company and has formulated a very ambitious plan.

Of course, the early stage will be dominated by land hoarding.

As long as the local government knows that Wanjiang Real Estate Company is a subsidiary of Wujiang Group, it is not easy for Wanjiang Real Estate to acquire land at a low price. In addition, the local government also hopes that after Wanjiang Real Estate acquires the land, it will carry out real estate development, so as to prosper and stimulate the local economy and achieve a win-win situation.

……

Zhao Ye really didn't dare to imagine that Wanjiang Real Estate Company, with his own support, would become a few Wanda Groups, at least more than five or six Wanda Groups, maybe more than ten is not impossible.

This year is 1994, and it is also the first year of the establishment of Wanda Group, Wang Jianlin may not have dreamed that Wanda Group has become a unit of measurement in Zhao Ye's mouth. (Wang Jianlin: Nima, don't I want to lose face?) ）

Zhao Ye was very satisfied with Xu Shengzhe's plan, as soon as he made a move, it was extraordinary, these 20 cities were the top 20 cities in the previous life, and their real estate market naturally had great development potential!

At this time, Zhao Ye picked up another document on the table, which contained a research report on the investment and construction of Wujiang Hospital.

In Zhao Ye's plan, he will take the lead in building a modern comprehensive tertiary first-class hospital integrating medical treatment, teaching and scientific research in each of the four cities of BJ, Shanghai, Guangzhou and Shenzhen, with an investment of no less than 3 billion US dollars in each hospital.

At this time, the location of the hospital has not yet been determined, but it will generally cooperate with Wanjiang Real Estate to increase the value of Wanjiang Real Estate development projects.

Generally speaking, real estate projects close to hospitals, schools, shopping malls, and government agencies have great potential for appreciation.

With the support of Wujiang Group, Wanjiang Real Estate can guarantee at least the first three points in its projects.

For the time being, the construction of Wujiang Hospital is not the most urgent.

However, the development of Wujiang Medicine can be put on the agenda.

The pharmaceutical industry is known as the "three high" industry, that is, high profits, high returns, high investment, the industry generally believes that a new drug from research and development to marketing generally takes 10 years, an investment of 1 billion US dollars. Therefore, the pharmaceutical industry has become a monopoly industry, with strong barriers and high technology content, and the general small and medium-sized enterprises simply cannot afford the high cost of research and development, and large enterprises do not dare to invest rashly, and the pharmaceutical research and development project is a high-risk project, with a success rate of less than 10%. In view of this, China's pharmaceutical industry started not late, but R&D investment cannot keep up, capital accumulation is small, marketing is important, scientific research is light, and generic drugs are the mainstay.

At present, the vast majority of the profits in the pharmaceutical market are occupied by foreign pharmaceutical companies. The research and development of new human drugs, especially in the field of cancer and cardiovascular and cerebrovascular diseases, are basically contributed by the Western world.

According to the Beijing News, in 2022, Pfizer's net profit will reach $31.3 billion!! It is more than six times the total profit of China's top 10 pharmaceutical companies in 2020!

How exaggerated this data is! It's shocking!

Chinese medicine has been dumped N streets by American pharmaceutical companies!!

If we don't catch up, the gap will only get bigger.

Zhao Ye felt that he had an opportunity to change China's pharmaceutical industry, not only to drive foreign drugs out of the Chinese market, but also to enter the international pharmaceutical market and seize the market share of European and American pharmaceutical companies.

At this time, Wujiang Group has spent money to hire headhunters to poach people from major pharmaceutical companies around the world.

It is expected that it will not be long before Borderless Pharmaceutical will become full of talent.

Zhao Ye also has high hopes for Wujiang Pharmaceutical Company, and there is no upper limit on investment, and the development of three major types of drugs (traditional Chinese medicine, biological drugs, and chemical drugs) can be carried out at the same time.

Chinese medicines include decoction pieces, proprietary Chinese medicines and Chinese herbal medicines.

Biologics include vaccines, serum, and blood products.

Chemical drugs include chemical raw materials and their preparations, antibiotics and so on.

These three types of drugs treat different diseases and can be prescribed according to the actual situation.

Right now, Wujiang Pharmaceutical's top priority is to apply for a patent for traditional Chinese medicine.

Just as South Korea likes to apply Chinese culture to the World Heritage List, Japan is good at preemptively registering patents for traditional Chinese medicine prescriptions internationally.

South Korea steals culture, Japan steals traditional Chinese medicine, it can be said that there is a clear division of labor.

Not only that, but Japan has even registered patents for the herbs used to make traditional Chinese medicine, which is extremely shameless.

In the previous life, Japan preemptively registered more than 70% of the world's patent medicine patents, compared to China's share of Chinese medicine patents accounting for only 0.3%. In addition to this, Japan also monopolizes 90% of the global TCM market. Traditional Chinese medicine has become a powerful tool for Japan.

It's a pity that in this life, the conspiracy of Japanese pharmaceutical companies will not succeed!

Wujiang Pharmaceutical Co., Ltd. will carry the banner of Chinese traditional Chinese medicine and promote Chinese patent medicine to the world!!

……

With the help of the huge resources of Wujiang Group, Wujiang Pharmaceutical Company counted how many traditional Chinese medicine companies and how many traditional Chinese medicine formulas there are in the country for the first time.

Traditional Chinese medicine has a long history, and there is no need for Wujiang Pharmaceutical Company to re-develop traditional Chinese medicine products, but only need to invest in those time-honored pharmaceutical companies, such as Rentang, Jiuzhitang, Guangyuyuan, Yunnan Baiyao, Chen Liji, Huiren, Dong'e, Zhongjing, Half the Sky, Baiyunshan, Renhe, Yangwuji, Harbin Medicine, Pan Gaoshou, Jingxiutang, Caizhilin, Ma Yinglong, etc......

Perhaps under the influence of Wujiang Pharmaceutical Company, traditional Chinese medicine will also rise again, recast its glory, and become the pride of the Chinese people!

Now, Zhao Ye even can't wait to see the rise of traditional Chinese medicine. Over the past 100 years, the west wind has pressed the east wind, suppressing our treasure - traditional Chinese medicine very ruthlessly, plus some people with ulterior motives have specially flattered the outside and suppressed the inside, resulting in the failure of our excellent traditional culture to develop.

Wujiang Pharmaceutical Company is now searching, collecting, and sorting out the remaining wealth of its ancestors, and the day of the rise of Chinese medicine should not be far off.

……

At this time, Borderless Pharma seconded the staff of the parent company to start the investment plan.

Zhao Ye made a big deal and directly invested 50 billion yuan in a time-honored Chinese medicine company for Wujiang Pharmaceutical Company, and if it was not enough anyway, he would make additional investment.

Fan Bohan, the general manager of Tongrentang Company, was surprised that people from Wujiang Group would come to their company to discuss business.

"Mr. Fan, hello, my name is Zhou Weimin, on behalf of Wujiang Pharmaceutical Company, I want to invest in Tongrentang!" Zhou Weimin, a representative of Wujiang Group, said straight to the point.

Fan Bohan was stunned when he heard this, obviously he didn't expect the other party to have this purpose, and before he could speak, the other party said: "Tong Ren Tang's income last year was only more than 400 million yuan, and Wujiang Pharmaceutical Company is willing to invest 500 million yuan in Tong Ren Tang, accounting for 49% of the shares!" ”

The investment of 500 million accounts for 49% of the shares???

Fan Bohan couldn't help but smack his tongue.

"Hello, Mr. Zhou. Tong Ren Tang belongs to a central enterprise, and the investment is too big for me to make a decision. Fan Bohan shook his head and said.

Zhou Weimin said with a smile: "I know that Tongrentang is a central enterprise, so Mr. Fan can report this matter to the leaders above." ”

"Okay, I'll reflect that to the above." Fan Bohan nodded and said, but then couldn't help asking, "Mr. Zhou, take the liberty of asking, why does Wujiang Pharmaceutical Company invest in Tongrentang Company?" ”

Zhou Weimin replied: "Because Wujiang Pharmaceutical Company intends to carry forward Chinese medicine and traditional Chinese medicine, I hope that one day, Chinese medicine halls can once again spread all over the land of China, benefit the people, and regain the glory of the past." ”

After a pause, Zhou Weimin continued, "Founded in 1669, Tong Ren Tang is one of the most famous time-honored brands in the Chinese medicine industry in China! To tell you the truth, we at Wujiang Pharmaceutical Company not only want to invest in Tong Ren Tang, but also invest in other time-honored Chinese medicine companies. At present, the decline of traditional Chinese medicine and the fact that traditional Chinese medicine patents are being preemptively registered by Japanese pharmaceutical companies are in a grim situation, but domestic pharmaceutical companies generally lack awareness and do not know the importance of patents to pharmaceutical companies. In the long run, more and more Chinese medicine patents will be preemptively registered by Japanese pharmaceutical companies, and at that time, China's entire Chinese medicine industry will be subject to Japan! ”

Speaking of this, Zhou Weimin's face became serious.

He has studied in Japan and has been exposed to Japanese proprietary Chinese medicine, and has a good understanding of Japan's determination to develop proprietary Chinese medicine.

Traditional Chinese medicine is the quintessence of China, but on the Chinese side, traditional Chinese medicine is wildly devalued, while in Japan, Chinese patent medicine is very popular, which is quite ironic.

When Zhou Weimin learned about the Chinese medicine investment plan of Wujiang Pharmaceutical Company, he took the initiative to ask Ying to participate in this plan.

Although Fan Bohan also knows the importance of patents, he doesn't know much.

Many of Tong Ren Tang's traditional Chinese medicines are almost unpatented.

……

For state-owned enterprises or central enterprises, Wujiang Pharmaceutical Company generally focuses on investment.

For private companies, direct acquisitions are made as much as possible, followed by investments.

Jiuzhitang is a private company, and the people sent by Wujiang Pharmaceutical Company proposed to acquire it.

As a private enterprise, Jiuzhitang's scale is naturally not as good as Rentang, and it was later acquired by Yongjin Group, and Wei Dong, a genius in the financial industry, became the head of Jiuzhitang, which will happen in the next few years, which can be said to have caused a great sensation in the industry at that time. A genius from the financial world has sat on the first position of a famous pharmaceutical company, which is more or less unexpected!

Jiuzhitang was of course unresistant in the face of the acquisition of Wujiang Pharmaceutical Company, and the shareholders of Jiuzhitang couldn't help but accept the lucrative offer of Wujiang Pharmaceutical Company.

At the same time, more than a dozen private pharmaceutical companies such as Qianjin Pharmaceutical, Huiren and Renhe have accepted the acquisition of Wujiang Pharmaceutical Company.

No way, the money is very in place.

State-owned enterprises such as Tongrentang, Baiyunshan Chen Liji Pharmaceutical Factory, Guangyuyuan, and Pien Tze Huang also chose to accept investment from Wujiang Pharmaceutical Company, but none of the shares exceeded 50%, but the minimum number of shares held reached 25%.

(End of chapter)